BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23015401)

  • 1. p63 Expression is a prognostic factor in colorectal cancer.
    Guo HQ; Huang GL; Liu OF; Liu YY; Yao ZH; Yao SN; Zhao Y; Liu T; Pu XX; Lin TY; Yang SJ
    Int J Biol Markers; 2012 Oct; 27(3):e212-8. PubMed ID: 23015401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
    Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
    Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TKTL1 and p63 are biomarkers for the poor prognosis of gastric cancer patients.
    Song Y; Liu D; He G
    Cancer Biomark; 2015; 15(5):591-7. PubMed ID: 26406948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
    Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y
    Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of activating transcription factor 7 is correlated with prognosis of colorectal cancer.
    Guo HQ; Ye S; Huang GL; Liu L; Liu OF; Yang SJ
    J Cancer Res Ther; 2015; 11(2):319-23. PubMed ID: 26148593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
    Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
    Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
    Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.
    Katsuki T; Nakayama Y; Akiyama M; Sawatsubashi Y; Nagata J; Minagawa N; Torigoe T; Izumi H; Kohono K; Hirata K
    Anticancer Res; 2018 Jan; 38(1):569-575. PubMed ID: 29277826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.
    Koelzer VH; Herrmann P; Zlobec I; Karamitopoulou E; Lugli A; Stein U
    BMC Cancer; 2015 Mar; 15():160. PubMed ID: 25884643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating transcription factor 1 is a prognostic marker of colorectal cancer.
    Huang GL; Guo HQ; Yang F; Liu OF; Li BB; Liu XY; Lu Y; He ZW
    Asian Pac J Cancer Prev; 2012; 13(3):1053-7. PubMed ID: 22631637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
    Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
    Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.
    Niu Y; Wang L; Cheng C; Du C; Lu X; Wang G; Liu J
    APMIS; 2015 Feb; 123(2):93-101. PubMed ID: 25257341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
    Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma.
    Jiang YH; Cheng B; Ge MH; Zhang G
    Head Neck Oncol; 2012 Mar; 4():9. PubMed ID: 22452794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
    Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
    Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A16 is a prognostic marker for colorectal cancer.
    Sun X; Wang T; Zhang C; Ning K; Guan ZR; Chen SX; Hong TT; Hua D
    J Surg Oncol; 2018 Feb; 117(2):275-283. PubMed ID: 28876468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.